Ioannis ZERDES | PostDoc / Licensed Physician | MD PhD | Karolinska Institutet, Solna | KI | Department of Oncology-Pathology
Ioannis ZERDES | PostDoc / Licensed Physician | MD PhD | Karolinska Institutet, Solna | KI | Department of Oncology-Pathology
Ioannis ZERDES | PostDoc / Licensed Physician | MD PhD | Karolinska Institutet, Solna | KI | Department of Oncology-Pathology
Ioannis Zerdes - Oncology Resident - Karolinska University Hospital | LinkedIn
Ioannis Zerdes - Civil Engineer - Self-employed engineering, management & grant consultant. | LinkedIn
Ioannis Zerdes - Oncology Resident - Karolinska University Hospital | LinkedIn
Ioannis Zerdes - Civil Engineer - Self-employed engineering, management & grant consultant. | LinkedIn
Zerdes Ioannis Katsiapis Nikolaos in Pireas, Greece Information and Review
Ioannis Zerdes - Oncology Resident - Karolinska University Hospital | LinkedIn
Ioannis ZERDES | PostDoc / Licensed Physician | MD PhD | Karolinska Institutet, Solna | KI | Department of Oncology-Pathology
Ioannis Zerdes - Civil Engineer - Self-employed engineering, management & grant consultant. | LinkedIn
TOKYO, JAPAN - AUGUST 2: Angelos Vlachopoulos of Greece, Konstantinos Gkiouvetsis of Greece, Christodoulos Kolomvos of Greece, Konstantinos Mourikis of Greece, Stylianos Argyropoulos of Greece, Georgios Dervisis of Greece, Alexandros Papanastasiou of
TOKYO, JAPAN - AUGUST 8: Silver for team Greece with head coach Theodoros Vlachos of Greece, Emmanouil Zerdevas of Greece, Konstantinos Genidounias of Greece, Dimitrios Skoumpakis of Greece, Marios Kapotsis of Greece,
PDF) Beyond PD-1/PD-L1 Inhibition: What the Future Holds for Breast Cancer Immunotherapy
Cancers | Free Full-Text | Discordance of PD-L1 Expression at the Protein and RNA Levels in Early Breast Cancer
Interplay between copy number alterations and immune profiles in the early breast cancer Scandinavian Breast Group 2004-1 randomized phase II trial: results from a feasibility study | npj Breast Cancer
Ioannis Zerdes - Civil Engineer - Self-employed engineering, management & grant consultant. | LinkedIn
Cancers | Free Full-Text | STAT3 Activity Promotes Programmed-Death Ligand 1 Expression and Suppresses Immune Responses in Breast Cancer
Ioannis Zerdes (ioanniszerdes) - Profile | Pinterest
Cancers | Free Full-Text | Discordance of PD-L1 Expression at the Protein and RNA Levels in Early Breast Cancer
Genetic, transcriptional and post-translational regulation of the programmed death protein ligand 1 in cancer: biology and clinical correlations | Oncogene
Cancers | Free Full-Text | STAT3 Activity Promotes Programmed-Death Ligand 1 Expression and Suppresses Immune Responses in Breast Cancer
